Show simple item record

dc.contributor.author Abdullahi, Fadumo Mohamed
dc.contributor.authorTornes, Yarine Fajardo 
dc.contributor.authorMigisha, Richard 
dc.contributor.authorKalyebara, Paul Kato 
dc.contributor.authorTibaijuka, Leevan 
dc.contributor.author Ngonzi, Joseph
dc.contributor.authorKayondo, Musa 
dc.contributor.authorByamukama, Onesmus 
dc.contributor.authorTuranzomwe, Stuart 
dc.contributor.authorRwebazibwa, Joseph 
dc.contributor.authorAinomugisha, Brenda 
dc.contributor.author Kajabwangu, Rogers
dc.contributor.authorMugyenyi, Godfrey R. 
dc.contributor.authorLugobe, Henry Mark 
dc.date.accessioned2024-10-07T09:49:21Z
dc.date.available2024-10-07T09:49:21Z
dc.date.issued2024
dc.identifier.citationAbdullahi et al. (2024), HELLP syndrome and associated factors among pregnant women with preeclampsia/ eclampsia at a referral hospital in southwestern Uganda: a cross-sectional study. BMC Pregnancy and Childbirthen_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3852
dc.description.abstractBackground: Hemolysis Elevated Liver Enzymes Low Platelets (HELLP) syndrome, a complication of preeclampsia/ eclampsia, is associated with severe maternal morbidity and mortality. In resource-limited settings, such as Uganda, gaps in routine laboratory assessments may lead to under detection of HELLP syndrome. This study determined the prevalence and factors associated with HELLP syndrome among pregnant women with preeclampsia/eclampsia at Mbarara Regional Referral Hospital (MRRH), southwestern Uganda. Methods: A cross-sectional study was conducted at the high-risk ward of the MRRH from December 2022 to June 2023. Pregnant women diagnosed with preeclampsia or eclampsia were enrolled consecutively. Participants’ sociodemographic and clinical data were collected using an interviewer-administered questionnaire. The diagnosis of complete HELLP syndrome was made based on the Tennessee classification: aspartate aminotransferase enzyme ≥ 70 IU/L, platelet counts < 100,000 cells/µL, and serum lactate dehydrogenase enzyme ≥ 600 IU/L. We used multivariable modified Poisson regression analysis to determine factors associated with HELLP syndrome. Results: A total of 129 participants with a mean age of 28 ± 6.6 years were enrolled in the study. The prevalence of HELLP syndrome was 18.6% (n = 24; 95% CI: 12.7–26.3%). Independent factors associated with HELLP syndrome were maternal age (adjusted prevalence ratio [aPR]: 4.96; 95% CI: 1.57–15.65; for mothers aged < 20 years compared to those aged 20–34 years), the presence of epigastric pain (aPR: 5.89; 95% CI: 1.41–14.63), and referral from other health facilities (aPR: 3.14; 95% CI: 1.27–7.72). Conclusion: Approximately 2 of the 10 women who presented with preeclampsia or eclampsia had HELLP syndrome. It is more common among teenage mothers, those with a history of epigastric pain and those referred from lower health facilities. Incorporating routine laboratory testing for HELLP syndrome in the diagnostic protocol for preeclampsia or eclampsia, especially among adolescent mothers, those experiencing epigastric pain, and those referred from lower health facilities, could enhance timely detection and management of mothers with preeclampsia whose pregnancies are complicated by HELLP syndrome.en_US
dc.language.isoen_USen_US
dc.publisherBMC Pregnancy and Childbirthen_US
dc.subjectHELLP syndromeen_US
dc.subjectPreeclampsiaen_US
dc.subjectEclampsiaen_US
dc.subjectUgandaen_US
dc.subjectPrevalenceen_US
dc.titleHELLP syndrome and associated factors among pregnant women with preeclampsia/ eclampsia at a referral hospital in southwestern Uganda: a cross-sectional studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record